Discovery and characterization of ACT-335827, an orally available, brain penetrant orexin receptor type 1 selective antagonist
ACT-335827 的发现和表征，一种口服的、脑渗透性食欲素受体 1 型选择性拮抗剂
期刊:ChemMedChem
影响因子:3.6
doi:10.1002/cmdc.201300003
Michel A Steiner, John Gatfield, Catherine Brisbare-Roch, Hendrik Dietrich, Alexander Treiber, Francois Jenck, Christoph Boss
